Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP928315.RArdNow51P47bCmGGHJzldkVcbZEjX-qVliVydmcNg6VM130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928315.RArdNow51P47bCmGGHJzldkVcbZEjX-qVliVydmcNg6VM130_provenance.
• NP351939.RAp5CSMsYh9ZuXcTQ7ANqll9M1HOp7iaOdd67USPklMS0130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351939.RAp5CSMsYh9ZuXcTQ7ANqll9M1HOp7iaOdd67USPklMS0130_provenance.
• NP654768.RApwMl7UwTw41wzFTQ1TLeKZ0oxvYyROkweO4-5w6Ngko130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654768.RApwMl7UwTw41wzFTQ1TLeKZ0oxvYyROkweO4-5w6Ngko130_provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP809422.RAxJ1Yq7mxn5aBcfZsFeaWJ2Qv1MMKx9KhSdTjOkLrbr8130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809422.RAxJ1Yq7mxn5aBcfZsFeaWJ2Qv1MMKx9KhSdTjOkLrbr8130_provenance.
• NP709127.RA3A3XWWH3Cv2koBI3JJVtOn6rhpMTfWiSpV5LMWPuV_w130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709127.RA3A3XWWH3Cv2koBI3JJVtOn6rhpMTfWiSpV5LMWPuV_w130_provenance.
• NP402438.RAZBnKEtLkdyV-e7GZodVU_UQ95wQkzTAkBq45TcWcB94130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402438.RAZBnKEtLkdyV-e7GZodVU_UQ95wQkzTAkBq45TcWcB94130_provenance.
• NP402474.RAXgZJ7ooSxegKjoMQ-Xtb_j2RJAOcSqy9AYugljtWtCw130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402474.RAXgZJ7ooSxegKjoMQ-Xtb_j2RJAOcSqy9AYugljtWtCw130_provenance.
• NP402552.RAQsAv5nFRyvxeI-Xx2zgCf-10c2K_L8GlVj_3_8H2foM130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402552.RAQsAv5nFRyvxeI-Xx2zgCf-10c2K_L8GlVj_3_8H2foM130_provenance.
• NP402553.RAQiQnvb5jUVuzYQJe8o_vJe88QY0satHWRxkQ8kETJ64130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402553.RAQiQnvb5jUVuzYQJe8o_vJe88QY0satHWRxkQ8kETJ64130_provenance.
• NP661696.RAlRemzFm7cKG0-CWJO88Vs7yz7q0ZjypqgWeun2juIIU130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661696.RAlRemzFm7cKG0-CWJO88Vs7yz7q0ZjypqgWeun2juIIU130_provenance.
• NP661698.RAg5xXPIt5suq7e_PEPmwl-eU9emLKy3EncYkUkIM-mrE130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661698.RAg5xXPIt5suq7e_PEPmwl-eU9emLKy3EncYkUkIM-mrE130_provenance.
• NP402531.RAI0hKGIV5wtArUrXKus0aOOiRRV6NS9WzZRErd-kpfhE130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402531.RAI0hKGIV5wtArUrXKus0aOOiRRV6NS9WzZRErd-kpfhE130_provenance.
• NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661699.RAGW4Lu2nYYML0K7z7rcU8n7Wq7w7iDwVfIUnRjNPfkoE130_provenance.
• NP661695.RA3GVCmn4MMytDwrMKtflFQHQrDSizJ7d8CykhftWLvb8130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661695.RA3GVCmn4MMytDwrMKtflFQHQrDSizJ7d8CykhftWLvb8130_provenance.
• NP661697.RAwledWUaB-b4NZdSUhqONsfUXlWoTrNUgTnp8GmVcjKY130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661697.RAwledWUaB-b4NZdSUhqONsfUXlWoTrNUgTnp8GmVcjKY130_provenance.